IMV Inc. IMVIF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

40/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

IMV Inc. (IMVIF) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

→ Health

MOAT

46/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — IMVIF

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-4.37

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$-2.10	$96.72K	$-6.63M	-6858.6%
2017	$-2.48	$26.34K	$-9.6M	-36446.6%
2018	$-3.67	$60.04K	$-16.06M	-26750%
2019	$-4.25	$45.5K	$-21.1M	-46381.7%
2020	$-4.55	$3.16K	$-27.44M	-868765.3%
2021	$-4.89	$0.00	$-36.27M	-
2022	$-4.37	$0.00	$-36.49M	-